Cytochrome P450 3A inhibition by atazanavir and ritonavir, but not demography or drug formulation, influences saquinavir population pharmacokinetics in human immunodeficiency virus type 1-infected adults.
about
Cytochrome P450 3A inhibition by atazanavir and ritonavir, but not demography or drug formulation, influences saquinavir population pharmacokinetics in human immunodeficiency virus type 1-infected adults.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytochrome P450 3A inhibition ...... virus type 1-infected adults.
@en
Cytochrome P450 3A inhibition ...... virus type 1-infected adults.
@nl
type
label
Cytochrome P450 3A inhibition ...... virus type 1-infected adults.
@en
Cytochrome P450 3A inhibition ...... virus type 1-infected adults.
@nl
prefLabel
Cytochrome P450 3A inhibition ...... virus type 1-infected adults.
@en
Cytochrome P450 3A inhibition ...... virus type 1-infected adults.
@nl
P2860
P356
P1476
Cytochrome P450 3A inhibition ...... virus type 1-infected adults.
@en
P2093
Nils von Hentig
P2860
P304
P356
10.1128/AAC.00025-09
P407
P577
2009-06-15T00:00:00Z